Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol Metabolism and PK in Healthy Males
NCT02194257Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of Ambroxol hydrochloride oral solution (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Individual time course profiles of [14C]-radioactivity in plasma up to 120 hours, Individual time course profiles of ambroxol in plasma up to 120 hours and 16 more. Started Oct 2008; status: completed.
02
Drugs
Ambroxol hydrochloride oral solution
Beyond the preview
Go deeper on NCT02194257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194257.